Reimbursement & Acquisition

Reimbursement and Acquisition

Dealing with insurance coverage and reimbursement can be a headache, but Novartis is committed to making the process as painless as possible for you and your patients. This section of the site provides information and resources to help make the process as efficient as possible, including:

• Reimbursement Guide — Information about coverage and reimbursement for Sandostatin LAR® Depot and immediate release Sandostatin® (octreotide acetate) Injection, as well as steps to follow if your patient's insurance claim is denied
• Coding and Claims Processing — All the codes you need
• Acquisition — Several ways you can arrange to have Sandostatin LAR® available when you need it
• Programs and Support — Programs that can help qualified patients receive reimbursement for Sandostatin LAR® Depot
• Fast Answers — Don't waste time looking for answers. Find out what the Sandostatin® Therapy Support Hotline can do for you
• Useful Forms — Download claims forms, sample letters of medical necessity, and more

Important

This section of the site is intended to assist the physician in obtaining reimbursement for health care services. It is not intended to increase or maximize payment by any payer. Because coverage policies and coding often change, it is recommended that you check with your carrier frequently. This website is for informational purposes only, and nothing herein shall be construed as a statement, promise, or guarantee by Novartis Pharmaceuticals Corporation regarding levels of reimbursement, payment, or change. Furthermore, all codes provided herein are for informational purposes only and shall not be construed as a statement, promise, or guarantee that these codes are accurate or reimbursement will be received. The ultimate responsibility for correct coding lies with the physician or provider. This website is provided without warranty of any kind, express or implied.

The Sandostatin® Therapy Support Hotline is staffed by a specialty pharmaceutical company specializing in solving reimbursement challenges, and is not an affiliate of Novartis Pharmaceuticals Corporation.

One of the primary purposes of the Hotline is to provide information to help you understand insurers' policies. Novartis Pharmaceuticals Corporation, and the Hotline staff do not formally make appeals for Hotline callers, nor do we guarantee that you will be successful in obtaining insurance payments. Numerous factors affect third-party payment for medical products and services. The Hotline staff cannot anticipate or resolve all of these situations.